Skip to main content ( press enter )

Search

Reset filter
Displaying results 1068 - 1074 of 2559
The hunt for new ovarian cancer drugs
February is Ovarian Cancer Awareness Month and we sat down with Dr Kathleen Pishas to hear about her research looking at a rare form of ovarian cancer that often has poor survival – it’s called Low Grade Serous Ovarian... Read more
SABR shows unprecedented effectiveness in kidney cancer
A precisely targeted and high-powered form of radiotherapy can provide long-term cancer control for patients with inoperable kidney tumours, a Peter Mac-led trial has shown. The “FASTRACK II” trial involved 70 patients with... Read more
Peter Mac awarded five Grants-in-Aid to boost cancer research
Almost $1.8 million has been awarded to five Peter Mac Researchers by the Cancer Council Victoria (CCV) to improve a range of different cancer treatments.  Grants-in-Aid are awarded each year to fund high quality research... Read more
Lea Medal Winners 2024
From left: Board Chair Professor Maxine Morand, Dr Abby Douglas, Dr Dineika Chandrananda, CEO Professor Jason Payne We are proud to announce the winners of Peter Mac’s Lea Medal for 2024 are Dr Abby Douglas and Dr Dineika... Read more
Peter Mac a global centre of excellence for neuroendocrine tumours
The Peter Mac NET Unit Peter Mac’s Neuroendocrine Tumour (NET) Unit has again been recognised as a leading global centre of excellence for the treatment of these rare and complex tumours. Neuroendocrine tumours develop from... Read more
New approach to understanding extent of lung cancer at diagnosis
An Australian study has highlighted a way to improve pre-treatment testing of lung cancer patients, to better detect cancers that may have unknowingly spread. The SEISMIC study - a collaboration by Peter MacCallum Cancer Centre,... Read more
Back to top